GLP-1 Medications Show Medical Cost Benefits, With Adherence and Womens Health as Key Factors Despite higher overall treatment costs, diabetes and weight loss patients on second-generation GLP-1 medications experience meaningfully slower medical cost growth compared to matched non-usersthough maximizing this benefit hinges heavily on therapy adherence, according to a comprehensive new analysis by Aon
At the six-month mark I was at 148 lbs
Managing Side Effects While You Wait for Relief Practical strategies during the adjustment period include eating protein-rich, low-fat meals in small portions every 3-4 hours
This additional oversight reduces the risk of contamination, dosage inconsistencies, or unsafe formulations
The catch: most of the strong data on GLP-1 anti-inflammatory effects comes from studies done at standard clinical doses, not microdoses
This Phase 3 trial, completed in December of the previous year, enrolled participants with obesity and knee osteoarthritis
